Jonathan Roach
Concepts (256)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hepatoblastoma | 9 | 2026 | 52 | 2.350 |
Why?
| | Liver Neoplasms | 12 | 2026 | 777 | 1.920 |
Why?
| | Biliary Atresia | 6 | 2022 | 158 | 1.760 |
Why?
| | Medical Errors | 2 | 2025 | 119 | 1.340 |
Why?
| | Surgical Oncology | 8 | 2026 | 30 | 1.230 |
Why?
| | Specialties, Surgical | 2 | 2022 | 82 | 1.200 |
Why?
| | Pancreatic Neoplasms | 2 | 2026 | 926 | 1.040 |
Why?
| | Neoplasm Recurrence, Local | 8 | 2026 | 1145 | 1.030 |
Why?
| | Adrenal Cortex Neoplasms | 2 | 2025 | 65 | 1.000 |
Why?
| | Adrenocortical Carcinoma | 2 | 2025 | 67 | 1.000 |
Why?
| | Hepatectomy | 2 | 2026 | 274 | 0.980 |
Why?
| | Pancreatectomy | 2 | 2026 | 286 | 0.960 |
Why?
| | Kidney Neoplasms | 7 | 2026 | 412 | 0.950 |
Why?
| | Echinococcosis | 1 | 2026 | 9 | 0.950 |
Why?
| | Liver Transplantation | 6 | 2024 | 826 | 0.910 |
Why?
| | Laparoscopy | 4 | 2026 | 477 | 0.900 |
Why?
| | Carcinoma, Papillary | 1 | 2025 | 77 | 0.880 |
Why?
| | Appointments and Schedules | 1 | 2025 | 96 | 0.840 |
Why?
| | Child | 44 | 2026 | 22600 | 0.820 |
Why?
| | Catheterization, Central Venous | 1 | 2025 | 124 | 0.770 |
Why?
| | Robotic Surgical Procedures | 1 | 2026 | 183 | 0.770 |
Why?
| | Survival Rate | 11 | 2026 | 2089 | 0.770 |
Why?
| | Portoenterostomy, Hepatic | 3 | 2022 | 43 | 0.670 |
Why?
| | Child, Preschool | 23 | 2026 | 11790 | 0.670 |
Why?
| | Infant | 23 | 2026 | 10023 | 0.660 |
Why?
| | Carcinoma, Hepatocellular | 5 | 2024 | 370 | 0.620 |
Why?
| | Choledocholithiasis | 3 | 2025 | 20 | 0.610 |
Why?
| | Gallstones | 3 | 2025 | 35 | 0.610 |
Why?
| | Bile Acids and Salts | 1 | 2020 | 163 | 0.580 |
Why?
| | Surgeons | 2 | 2025 | 341 | 0.580 |
Why?
| | Pediatrics | 3 | 2025 | 1121 | 0.570 |
Why?
| | Retrospective Studies | 30 | 2026 | 17149 | 0.560 |
Why?
| | Cholestasis | 1 | 2020 | 213 | 0.530 |
Why?
| | Neoplasms | 4 | 2025 | 2873 | 0.520 |
Why?
| | Adolescent | 26 | 2026 | 22409 | 0.500 |
Why?
| | Quality Improvement | 2 | 2025 | 1287 | 0.500 |
Why?
| | Wilms Tumor | 3 | 2023 | 86 | 0.480 |
Why?
| | Appendectomy | 3 | 2023 | 90 | 0.470 |
Why?
| | Patient Safety | 1 | 2019 | 353 | 0.450 |
Why?
| | Adrenalectomy | 2 | 2025 | 68 | 0.440 |
Why?
| | Nephrectomy | 4 | 2026 | 158 | 0.440 |
Why?
| | Teratoma | 2 | 2026 | 124 | 0.440 |
Why?
| | Fellowships and Scholarships | 1 | 2019 | 355 | 0.440 |
Why?
| | Postoperative Complications | 5 | 2026 | 2950 | 0.430 |
Why?
| | Humans | 57 | 2026 | 144667 | 0.430 |
Why?
| | Pancreaticoduodenectomy | 2 | 2026 | 137 | 0.420 |
Why?
| | Accidents | 1 | 2014 | 46 | 0.420 |
Why?
| | MicroRNAs | 1 | 2020 | 689 | 0.410 |
Why?
| | Appendicitis | 2 | 2023 | 150 | 0.400 |
Why?
| | Digestive System Diseases | 1 | 2013 | 27 | 0.390 |
Why?
| | Cholecystectomy, Laparoscopic | 2 | 2023 | 55 | 0.380 |
Why?
| | Tissue and Organ Harvesting | 1 | 2013 | 78 | 0.380 |
Why?
| | Abdomen | 1 | 2013 | 141 | 0.370 |
Why?
| | Sarcoma | 3 | 2024 | 203 | 0.350 |
Why?
| | Child Abuse | 2 | 2014 | 549 | 0.350 |
Why?
| | Kidney Failure, Chronic | 1 | 2017 | 597 | 0.340 |
Why?
| | Internship and Residency | 1 | 2022 | 1262 | 0.330 |
Why?
| | Kidney Transplantation | 1 | 2017 | 709 | 0.330 |
Why?
| | Organ Transplantation | 1 | 2013 | 247 | 0.310 |
Why?
| | Ovarian Neoplasms | 2 | 2026 | 589 | 0.310 |
Why?
| | Tissue Donors | 1 | 2013 | 413 | 0.310 |
Why?
| | Bile Ducts | 2 | 2020 | 67 | 0.290 |
Why?
| | Brain Injuries | 1 | 2014 | 506 | 0.290 |
Why?
| | Blood Substitutes | 1 | 2009 | 27 | 0.290 |
Why?
| | Inflammation | 1 | 2020 | 2870 | 0.290 |
Why?
| | Neoplasm Staging | 4 | 2026 | 1465 | 0.280 |
Why?
| | Heme Oxygenase-1 | 1 | 2009 | 74 | 0.280 |
Why?
| | Cholangiopancreatography, Endoscopic Retrograde | 3 | 2025 | 221 | 0.270 |
Why?
| | Abdominal Abscess | 1 | 2007 | 25 | 0.270 |
Why?
| | Cellulitis | 1 | 2007 | 53 | 0.260 |
Why?
| | Female | 26 | 2026 | 78304 | 0.260 |
Why?
| | Male | 24 | 2026 | 72431 | 0.250 |
Why?
| | United States | 6 | 2026 | 16018 | 0.250 |
Why?
| | Cytokines | 2 | 2018 | 2045 | 0.250 |
Why?
| | Drainage | 1 | 2007 | 184 | 0.240 |
Why?
| | Endodermal Sinus Tumor | 1 | 2026 | 10 | 0.240 |
Why?
| | Hemoglobins | 1 | 2009 | 381 | 0.240 |
Why?
| | Lung Neoplasms | 3 | 2026 | 2660 | 0.240 |
Why?
| | Conversion to Open Surgery | 1 | 2026 | 22 | 0.240 |
Why?
| | Indocyanine Green | 1 | 2026 | 42 | 0.240 |
Why?
| | Metastasectomy | 1 | 2026 | 19 | 0.230 |
Why?
| | Liver | 3 | 2026 | 1889 | 0.230 |
Why?
| | Esophageal Atresia | 1 | 2026 | 32 | 0.230 |
Why?
| | Sentinel Lymph Node | 1 | 2026 | 49 | 0.230 |
Why?
| | Tracheoesophageal Fistula | 1 | 2026 | 40 | 0.230 |
Why?
| | Tomography, X-Ray Computed | 2 | 2022 | 2754 | 0.230 |
Why?
| | Near Miss, Healthcare | 1 | 2025 | 12 | 0.220 |
Why?
| | Lipopolysaccharides | 1 | 2009 | 854 | 0.220 |
Why?
| | Sentinel Lymph Node Biopsy | 1 | 2026 | 117 | 0.220 |
Why?
| | Operative Time | 1 | 2026 | 181 | 0.220 |
Why?
| | Carcinoma, Medullary | 1 | 2025 | 16 | 0.220 |
Why?
| | Intraoperative Care | 1 | 2025 | 63 | 0.220 |
Why?
| | Length of Stay | 3 | 2026 | 1339 | 0.220 |
Why?
| | Rhabdoid Tumor | 1 | 2026 | 102 | 0.210 |
Why?
| | Soft Tissue Neoplasms | 1 | 2026 | 128 | 0.210 |
Why?
| | Trisomy 18 Syndrome | 1 | 2024 | 5 | 0.210 |
Why?
| | Databases, Factual | 3 | 2026 | 1494 | 0.210 |
Why?
| | Mesenteric Veins | 1 | 2024 | 23 | 0.210 |
Why?
| | Clinical Protocols | 1 | 2026 | 282 | 0.210 |
Why?
| | Pancreatitis | 1 | 2025 | 145 | 0.210 |
Why?
| | Infant, Newborn | 7 | 2026 | 6399 | 0.210 |
Why?
| | Minimally Invasive Surgical Procedures | 1 | 2025 | 189 | 0.210 |
Why?
| | Pancreas | 1 | 2026 | 341 | 0.200 |
Why?
| | Appendiceal Neoplasms | 1 | 2023 | 28 | 0.200 |
Why?
| | Recurrent Laryngeal Nerve Injuries | 1 | 2023 | 16 | 0.190 |
Why?
| | Sarcoma, Ewing | 1 | 2024 | 103 | 0.190 |
Why?
| | Neoplasms, Germ Cell and Embryonal | 1 | 2024 | 76 | 0.190 |
Why?
| | Intraoperative Neurophysiological Monitoring | 1 | 2023 | 32 | 0.190 |
Why?
| | Combined Modality Therapy | 4 | 2026 | 1268 | 0.190 |
Why?
| | Follow-Up Studies | 7 | 2026 | 5414 | 0.180 |
Why?
| | Documentation | 1 | 2024 | 198 | 0.180 |
Why?
| | Treatment Outcome | 6 | 2026 | 11735 | 0.180 |
Why?
| | Prognosis | 6 | 2026 | 4312 | 0.180 |
Why?
| | Blood Transfusion | 1 | 2025 | 405 | 0.180 |
Why?
| | Registries | 2 | 2025 | 2392 | 0.180 |
Why?
| | Solitary Pulmonary Nodule | 1 | 2022 | 25 | 0.180 |
Why?
| | Multiple Pulmonary Nodules | 1 | 2022 | 23 | 0.180 |
Why?
| | Academic Medical Centers | 1 | 2025 | 545 | 0.180 |
Why?
| | Neuroendocrine Tumors | 1 | 2023 | 119 | 0.170 |
Why?
| | Bone Neoplasms | 1 | 2024 | 255 | 0.170 |
Why?
| | CD79 Antigens | 1 | 2020 | 16 | 0.160 |
Why?
| | Thoracic Wall | 1 | 2020 | 21 | 0.160 |
Why?
| | Thoracic Neoplasms | 1 | 2020 | 39 | 0.160 |
Why?
| | Cell Line | 2 | 2020 | 2821 | 0.160 |
Why?
| | Short Bowel Syndrome | 1 | 2020 | 27 | 0.160 |
Why?
| | Age Factors | 2 | 2025 | 3329 | 0.150 |
Why?
| | Young Adult | 6 | 2026 | 14122 | 0.150 |
Why?
| | Hepatocytes | 1 | 2020 | 221 | 0.150 |
Why?
| | Digestive System Surgical Procedures | 1 | 2020 | 110 | 0.150 |
Why?
| | Health Knowledge, Attitudes, Practice | 2 | 2025 | 1406 | 0.150 |
Why?
| | Receptors, Cytoplasmic and Nuclear | 1 | 2020 | 204 | 0.140 |
Why?
| | Skin Neoplasms | 1 | 2026 | 850 | 0.140 |
Why?
| | Scoliosis | 1 | 2020 | 224 | 0.130 |
Why?
| | Membrane Glycoproteins | 1 | 2020 | 496 | 0.130 |
Why?
| | Surveys and Questionnaires | 2 | 2022 | 6041 | 0.130 |
Why?
| | Healthcare Disparities | 1 | 2024 | 736 | 0.120 |
Why?
| | Clinical Competence | 1 | 2025 | 1237 | 0.120 |
Why?
| | Critical Pathways | 1 | 2018 | 108 | 0.120 |
Why?
| | Job Satisfaction | 1 | 2019 | 235 | 0.120 |
Why?
| | Carrier Proteins | 1 | 2020 | 733 | 0.120 |
Why?
| | Electronic Health Records | 1 | 2024 | 1176 | 0.120 |
Why?
| | Postoperative Care | 1 | 2018 | 286 | 0.120 |
Why?
| | Perioperative Care | 1 | 2017 | 231 | 0.110 |
Why?
| | Child Advocacy | 1 | 2014 | 31 | 0.100 |
Why?
| | Disease-Free Survival | 2 | 2026 | 768 | 0.100 |
Why?
| | Choledochal Cyst | 1 | 2013 | 17 | 0.100 |
Why?
| | Disease Models, Animal | 3 | 2020 | 4539 | 0.100 |
Why?
| | Bile Ducts, Intrahepatic | 1 | 2013 | 63 | 0.100 |
Why?
| | Lymph Node Excision | 2 | 2025 | 173 | 0.100 |
Why?
| | Mice, Knockout | 1 | 2020 | 3109 | 0.100 |
Why?
| | Analgesics, Opioid | 1 | 2022 | 1142 | 0.100 |
Why?
| | Patient Selection | 1 | 2017 | 727 | 0.100 |
Why?
| | Bilirubin | 2 | 2023 | 99 | 0.090 |
Why?
| | B-Lymphocytes | 1 | 2018 | 875 | 0.090 |
Why?
| | Forecasting | 1 | 2014 | 391 | 0.090 |
Why?
| | Craniocerebral Trauma | 1 | 2014 | 178 | 0.090 |
Why?
| | Gene Expression Regulation | 1 | 2020 | 2591 | 0.080 |
Why?
| | Preoperative Care | 1 | 2013 | 379 | 0.080 |
Why?
| | Time Factors | 3 | 2018 | 7140 | 0.080 |
Why?
| | Mice | 3 | 2020 | 18261 | 0.080 |
Why?
| | Diagnosis, Differential | 1 | 2014 | 1501 | 0.080 |
Why?
| | Protoporphyrins | 1 | 2009 | 14 | 0.070 |
Why?
| | Enzyme Induction | 1 | 2009 | 88 | 0.070 |
Why?
| | Active Transport, Cell Nucleus | 1 | 2009 | 120 | 0.070 |
Why?
| | Transcription Factor RelA | 1 | 2009 | 85 | 0.070 |
Why?
| | Adult | 5 | 2025 | 40489 | 0.070 |
Why?
| | Gelsolin | 1 | 2007 | 10 | 0.070 |
Why?
| | Aged | 2 | 2025 | 25955 | 0.070 |
Why?
| | Intestinal Perforation | 1 | 2007 | 46 | 0.070 |
Why?
| | Lymph | 1 | 2007 | 31 | 0.070 |
Why?
| | Colorado | 2 | 2014 | 4558 | 0.060 |
Why?
| | alpha-Fetoproteins | 1 | 2026 | 42 | 0.060 |
Why?
| | Middle Aged | 2 | 2025 | 35971 | 0.060 |
Why?
| | Animals | 4 | 2020 | 37948 | 0.060 |
Why?
| | Parenteral Nutrition, Total | 1 | 2026 | 30 | 0.060 |
Why?
| | Tuberous Sclerosis | 1 | 1986 | 56 | 0.060 |
Why?
| | Thoracoscopy | 1 | 2026 | 60 | 0.060 |
Why?
| | Cell Nucleus | 1 | 2009 | 592 | 0.060 |
Why?
| | Enzyme Inhibitors | 1 | 2009 | 820 | 0.060 |
Why?
| | Cholecystectomy | 1 | 2025 | 61 | 0.060 |
Why?
| | Shock, Hemorrhagic | 1 | 2007 | 202 | 0.050 |
Why?
| | Biopsy, Large-Core Needle | 1 | 2024 | 15 | 0.050 |
Why?
| | Lymphatic Metastasis | 1 | 2026 | 334 | 0.050 |
Why?
| | Pylorus | 1 | 2024 | 17 | 0.050 |
Why?
| | Image-Guided Biopsy | 1 | 2024 | 41 | 0.050 |
Why?
| | Induction Chemotherapy | 1 | 2024 | 87 | 0.050 |
Why?
| | Enteral Nutrition | 1 | 2026 | 217 | 0.050 |
Why?
| | Kaplan-Meier Estimate | 1 | 2026 | 967 | 0.050 |
Why?
| | Delphi Technique | 1 | 2025 | 330 | 0.050 |
Why?
| | Remission Induction | 1 | 2024 | 309 | 0.050 |
Why?
| | Aspartate Aminotransferases | 1 | 2023 | 85 | 0.050 |
Why?
| | Recurrent Laryngeal Nerve | 1 | 2023 | 3 | 0.050 |
Why?
| | Common Bile Duct | 1 | 2023 | 14 | 0.050 |
Why?
| | Neuroblastoma | 1 | 2024 | 174 | 0.050 |
Why?
| | Lipase | 1 | 2023 | 75 | 0.050 |
Why?
| | Nephrons | 1 | 2022 | 23 | 0.050 |
Why?
| | Alanine Transaminase | 1 | 2023 | 151 | 0.050 |
Why?
| | Lymphoma | 1 | 2024 | 233 | 0.050 |
Why?
| | Monitoring, Intraoperative | 1 | 2023 | 66 | 0.050 |
Why?
| | Watchful Waiting | 1 | 2023 | 90 | 0.050 |
Why?
| | Thyroidectomy | 1 | 2023 | 91 | 0.050 |
Why?
| | Methylene Blue | 1 | 2022 | 24 | 0.040 |
Why?
| | Kidney Diseases | 1 | 1986 | 427 | 0.040 |
Why?
| | Patient Readmission | 1 | 2007 | 765 | 0.040 |
Why?
| | Thoracic Surgery, Video-Assisted | 1 | 2022 | 48 | 0.040 |
Why?
| | Prospective Studies | 2 | 2026 | 7994 | 0.040 |
Why?
| | Biopsy | 1 | 2024 | 1079 | 0.040 |
Why?
| | Neoadjuvant Therapy | 1 | 2024 | 464 | 0.040 |
Why?
| | Societies, Medical | 1 | 2025 | 890 | 0.040 |
Why?
| | Universities | 1 | 2003 | 452 | 0.040 |
Why?
| | Risk-Taking | 1 | 2003 | 324 | 0.040 |
Why?
| | Acute Disease | 1 | 2023 | 1029 | 0.040 |
Why?
| | Lymph Nodes | 1 | 2023 | 501 | 0.040 |
Why?
| | Markov Chains | 1 | 2020 | 130 | 0.040 |
Why?
| | Medicaid | 1 | 2024 | 464 | 0.040 |
Why?
| | Socioeconomic Factors | 1 | 2024 | 1322 | 0.040 |
Why?
| | Graft Survival | 1 | 2022 | 510 | 0.040 |
Why?
| | Sexual Behavior | 1 | 2003 | 493 | 0.040 |
Why?
| | Students | 1 | 2003 | 657 | 0.030 |
Why?
| | Adaptive Immunity | 1 | 2018 | 169 | 0.030 |
Why?
| | Anti-Bacterial Agents | 1 | 2007 | 1928 | 0.030 |
Why?
| | Clinical Decision-Making | 1 | 2020 | 360 | 0.030 |
Why?
| | Prevalence | 1 | 2023 | 2839 | 0.030 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2018 | 835 | 0.030 |
Why?
| | Spleen | 1 | 2018 | 510 | 0.030 |
Why?
| | Sequence Analysis, RNA | 1 | 2018 | 442 | 0.030 |
Why?
| | Animals, Newborn | 1 | 2018 | 890 | 0.030 |
Why?
| | Cell Culture Techniques | 1 | 2018 | 372 | 0.030 |
Why?
| | Disease Progression | 1 | 2023 | 2847 | 0.030 |
Why?
| | Mice, Inbred BALB C | 1 | 2018 | 1251 | 0.030 |
Why?
| | Neoplasm Metastasis | 1 | 2018 | 691 | 0.030 |
Why?
| | Survival Analysis | 1 | 2018 | 1370 | 0.030 |
Why?
| | Flow Cytometry | 1 | 2018 | 1154 | 0.030 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 1 | 2024 | 1961 | 0.030 |
Why?
| | Immunohistochemistry | 1 | 2018 | 1705 | 0.030 |
Why?
| | Dilatation, Pathologic | 1 | 2013 | 61 | 0.030 |
Why?
| | Morbidity | 1 | 2014 | 322 | 0.020 |
Why?
| | Practice Patterns, Physicians' | 1 | 2022 | 1360 | 0.020 |
Why?
| | Logistic Models | 1 | 2018 | 2114 | 0.020 |
Why?
| | Antineoplastic Agents | 1 | 2023 | 2201 | 0.020 |
Why?
| | Quality of Life | 1 | 2020 | 3183 | 0.020 |
Why?
| | Mesentery | 1 | 2007 | 44 | 0.020 |
Why?
| | Rupture, Spontaneous | 1 | 1986 | 15 | 0.020 |
Why?
| | Peritoneal Cavity | 1 | 1986 | 30 | 0.020 |
Why?
| | Fluid Therapy | 1 | 2007 | 148 | 0.020 |
Why?
| | Data Interpretation, Statistical | 1 | 2007 | 368 | 0.010 |
Why?
| | Actins | 1 | 2007 | 421 | 0.010 |
Why?
| | Mass Spectrometry | 1 | 2007 | 743 | 0.010 |
Why?
| | Midwestern United States | 1 | 2003 | 45 | 0.010 |
Why?
| | Rats, Sprague-Dawley | 1 | 2007 | 2521 | 0.010 |
Why?
| | Sexually Transmitted Diseases | 1 | 2003 | 163 | 0.010 |
Why?
| | Contraception | 1 | 2003 | 170 | 0.010 |
Why?
| | Proteomics | 1 | 2007 | 1183 | 0.010 |
Why?
| | Data Collection | 1 | 2003 | 635 | 0.010 |
Why?
| | School Health Services | 1 | 2003 | 221 | 0.010 |
Why?
| | Rats | 1 | 2007 | 5570 | 0.010 |
Why?
|
|
Roach's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|